基金经理：赵宗庭
| 单位净值:0.7041 | 净值增长率:-0.03% | 净值增长率:-0.03% | 累计净值:0.7041 | 截止日期:2025/1/22 | |
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:4.73亿元 | 风险等级:高风险 | 申购状态:不可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
华夏恒生生物科技ETF发起式联接(QDII)C(016971)申购赎回 |
||||||
|---|---|---|---|---|---|---|
| 报告期 | 期初总份额(份) | 期末总份额(份) | 期间总申购份额(份) | 期间总赎回份额(份) | 期间净申赎份额(份) | 净申赎比例 |
| 2024/12/31 | 530,862,000 | 672,028,000 | 741,198,000 | 600,032,000 | 141,166,000 | 26.59% |
| 2024/9/30 | 508,078,000 | 530,862,000 | 363,887,000 | 341,102,000 | 22,785,000 | 4.48% |
| 2024/6/30 | 472,211,000 | 508,078,000 | 1,002,520,000 | 966,653,000 | 35,867,000 | 7.6% |
| 2024/6/30 | 531,071,000 | 508,078,000 | 444,790,000 | 467,783,000 | -22,993,000 | -4.33% |
| 2024/3/31 | 472,211,000 | 531,071,000 | 557,729,000 | 498,870,000 | 58,859,000 | 12.46% |
| 2023/12/31 | 10,176,100 | 472,211,000 | 933,076,000 | 471,041,000 | 462,035,000 | 4540.39% |
| 2023/12/31 | 182,703,000 | 472,211,000 | 569,684,000 | 280,177,000 | 289,507,000 | 158.46% |
| 2023/9/30 | 95,863,600 | 182,703,000 | 206,853,000 | 120,013,000 | 86,840,000 | 90.59% |
| 2023/6/30 | 10,176,100 | 95,863,600 | 156,539,000 | 70,851,700 | 85,687,300 | 842.04% |
| 2023/6/30 | 26,591,900 | 95,863,600 | 124,435,000 | 55,163,400 | 69,271,600 | 260.5% |
| 2023/3/31 | 10,176,100 | 26,591,900 | 32,104,100 | 15,688,300 | 16,415,800 | 161.32% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。